PMID- 25986070
OWN - NLM
STAT- MEDLINE
DCOM- 20151228
LR  - 20221207
IS  - 1643-3750 (Electronic)
IS  - 1234-1010 (Print)
IS  - 1234-1010 (Linking)
VI  - 21
DP  - 2015 May 19
TI  - Glycemic control rate of T2DM outpatients in China: a multi-center survey.
PG  - 1440-6
LID - 10.12659/MSM.892246 [doi]
AB  - BACKGROUND: Type 2 diabetes mellitus (T2DM)-associated mortality and morbidity 
      are strongly dependent on glycemic control. With T2DM prevalence increasing in 
      China, we aimed to assess glycemic control rates in Chinese T2DM outpatients. 
      MATERIAL/METHODS: A total of 9065 adult T2DM outpatients (5035 men) were assessed 
      in 26 Chinese medical centers between August 2010 and April 2012. Patients were 
      stratified according to BMI (kg/m2): <24, 24-28, and >28. Successful glycemic 
      control was defined as glycated hemoglobin A1c (HbA1c) </=7% or fasting plasma 
      glucose (FPG) <7.0 mmol/L. RESULTS: Among the participants included in this 
      study, 2939 had BMI <24, 3361 had BMI of 24-28, and 2764 had BMI >28. The 
      glycemic control rate was only 32.6%, and the triple control rate for glycemia, 
      blood pressure, and lipidemia was only 11.2%. Glycemic control rates by BMI group 
      were 33.7% (<24), 33.8% (24-28), and 30.2% (>28) (p=0.005), and corresponding 
      incidences of cardiovascular diseases (CVD) were 12.2%, 15.7%, and 15.9% 
      (p<0.001). Multivariate logistic regression analysis demonstrated that older age 
      (p<0.001), higher BMI (p=0.026), larger waist circumference (p<0.001), less 
      education (p<0.001), and recent diagnosis (p<0.001) were independent risk factors 
      for poor glycemic control. CONCLUSIONS: The T2DM glycemic control rate in China 
      is currently low, especially in older obese patients with poor education and 
      recent diagnosis.
FAU - Chen, Rong
AU  - Chen R
AD  - Department of Endocrinology, Changhai Hospital of Second Military Medical 
      University of Chinese PLA, Shanghai, China (mainland).
FAU - Ji, Linong
AU  - Ji L
AD  - Department of Endocrinology, Peking University People's Hospital, Beijing, China 
      (mainland).
FAU - Chen, Liming
AU  - Chen L
AD  - Department of Metabolic Disease, Tianjin Medical University, Tianjin, China 
      (mainland).
FAU - Chen, Li
AU  - Chen L
AD  - Department of Endocrinology, Qilu Hospital of Shandong University, Jinan, 
      Shandong, China (mainland).
FAU - Cai, Dehong
AU  - Cai D
AD  - Department of Endocrinology, Zhujiang Hospital of First Military Medical 
      University, Guangzhou, Guangdong, China (mainland).
FAU - Feng, Bo
AU  - Feng B
AD  - Department of Endocrinology, Shanghai East Hospital, Shanghai, China (mainland).
FAU - Kuang, Hongyu
AU  - Kuang H
AD  - Department of Endocrinology, Harbin Medical University, Harbin, Heilongjiang, 
      China (mainland).
FAU - Li, Hong
AU  - Li H
AD  - Department of Endocrinology, Sir Run Run Shaw Hospital, School of Medicine, 
      Zhejiang University, Hangzhou, Zhejiang, China (mainland).
FAU - Li, Yiming
AU  - Li Y
AD  - Department of Endocrinology, Huashan Hospital of Fudan University, Shanghai, 
      China (mainland).
FAU - Liu, Jing
AU  - Liu J
AD  - Department of Endocrinology, Gansu Provincial Hospital, Lanzhou, Gansu, China 
      (mainland).
FAU - Shan, Zhongyan
AU  - Shan Z
AD  - Department of Endocrinology, First Affiliated Hospital of China Medical 
      University, Shenyang, Liaoning, China (mainland).
FAU - Sun, Zilin
AU  - Sun Z
AD  - Department of Endocrinology, Zhongda Hospital Southeast University, Nanjing, 
      Jiangsu, China (mainland).
FAU - Tian, Haoming
AU  - Tian H
AD  - Department of Endocrinology, West China Hospital, Sichuan University, Chengdu, 
      Sichuan, China (mainland).
FAU - Xu, Zhangrong
AU  - Xu Z
AD  - Department of Endocrinology, The 306th Hospital of PLA, Beijing, China 
      (mainland).
FAU - Xu, Yancheng
AU  - Xu Y
AD  - Department of Endocrinology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, 
      China (mainland).
FAU - Yang, Yuzhi
AU  - Yang Y
AD  - Department of Endocrinology, Heilongjiang Provincial Hospital, Harbin, 
      Heilongjiang, China (mainland).
FAU - Yang, Liyong
AU  - Yang L
AD  - Department of Endocrinology, First Affiliated Hospital of Fujian Medical 
      University, Fuzhou, Fujian, China (mainland).
FAU - Yu, Xuefeng
AU  - Yu X
AD  - Department of Endocrinology, Tongji Hospital, Wuhan, Hubei, China (mainland).
FAU - Zhu, Dalong
AU  - Zhu D
AD  - Department of Endocrinology, Nanjing Drum Tower Hospital, Affiliated Hospital of 
      Nanjing University Medical School, Nanjing, Jiangsu, China (mainland).
FAU - Zou, Dajin
AU  - Zou D
AD  - Department of Endocrinology, Changhai Hospital of Second Military Medical 
      University of Chinese PLA, Shanghai, China (mainland).
LA  - eng
PT  - Journal Article
PT  - Multicenter Study
PT  - Research Support, Non-U.S. Gov't
DEP - 20150519
PL  - United States
TA  - Med Sci Monit
JT  - Medical science monitor : international medical journal of experimental and 
      clinical research
JID - 9609063
RN  - 0 (Blood Glucose)
RN  - 0 (Glycated Hemoglobin A)
RN  - 0 (Lipids)
SB  - IM
MH  - Adult
MH  - Age Factors
MH  - Aged
MH  - Anthropometry
MH  - Blood Glucose/*analysis
MH  - Body Mass Index
MH  - Cardiovascular Diseases/epidemiology
MH  - China/epidemiology
MH  - Comorbidity
MH  - Diabetes Complications/epidemiology
MH  - Diabetes Mellitus, Type 2/*blood/drug therapy/epidemiology
MH  - Drug Monitoring
MH  - Educational Status
MH  - Female
MH  - Glycated Hemoglobin/*analysis
MH  - Humans
MH  - Lipids/blood
MH  - Male
MH  - Middle Aged
MH  - Outpatients/statistics & numerical data
MH  - Smoking/epidemiology
MH  - Treatment Outcome
PMC - PMC4448594
EDAT- 2015/05/20 06:00
MHDA- 2015/12/29 06:00
PMCR- 2015/05/19
CRDT- 2015/05/20 06:00
PHST- 2015/05/20 06:00 [entrez]
PHST- 2015/05/20 06:00 [pubmed]
PHST- 2015/12/29 06:00 [medline]
PHST- 2015/05/19 00:00 [pmc-release]
AID - 892246 [pii]
AID - 10.12659/MSM.892246 [doi]
PST - epublish
SO  - Med Sci Monit. 2015 May 19;21:1440-6. doi: 10.12659/MSM.892246.